Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer

Figure 3

Kaplan-Meier analysis of breast cancer specific survival showing the impact of low (black line) and high (grey line) calpain-9 expression in patients that did not receive endocrine therapy (A), and in those that did receive endocrine therapy (B); with significance determined using the log-rank test. The numbers shown below the Kaplan-Meier survival curves are the number of patients at risk at the specified month.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us